These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17921184)

  • 1. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.
    Kastrinaki MC; Sidiropoulos P; Roche S; Ringe J; Lehmann S; Kritikos H; Vlahava VM; Delorme B; Eliopoulos GD; Jorgensen C; Charbord P; Häupl T; Boumpas DT; Papadaki HA
    Ann Rheum Dis; 2008 Jun; 67(6):741-9. PubMed ID: 17921184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondrogenic potential of mesenchymal stem cells from patients with rheumatoid arthritis and osteoarthritis: measurements in a microculture system.
    Dudics V; Kunstár A; Kovács J; Lakatos T; Géher P; Gömör B; Monostori E; Uher F
    Cells Tissues Organs; 2009; 189(5):307-16. PubMed ID: 18562787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells.
    Djouad F; Bony C; Häupl T; Uzé G; Lahlou N; Louis-Plence P; Apparailly F; Canovas F; Rème T; Sany J; Jorgensen C; Noël D
    Arthritis Res Ther; 2005; 7(6):R1304-15. PubMed ID: 16277684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.
    Rebelatto CK; Aguiar AM; Moretão MP; Senegaglia AC; Hansen P; Barchiki F; Oliveira J; Martins J; Kuligovski C; Mansur F; Christofis A; Amaral VF; Brofman PS; Goldenberg S; Nakao LS; Correa A
    Exp Biol Med (Maywood); 2008 Jul; 233(7):901-13. PubMed ID: 18445775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells.
    Puissant B; Barreau C; Bourin P; Clavel C; Corre J; Bousquet C; Taureau C; Cousin B; Abbal M; Laharrague P; Penicaud L; Casteilla L; Blancher A
    Br J Haematol; 2005 Apr; 129(1):118-29. PubMed ID: 15801964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue.
    Shih DT; Lee DC; Chen SC; Tsai RY; Huang CT; Tsai CC; Shen EY; Chiu WT
    Stem Cells; 2005 Aug; 23(7):1012-20. PubMed ID: 15941858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia.
    Zhao Z; Tang X; You Y; Li W; Liu F; Zou P
    Leuk Res; 2006 Aug; 30(8):993-1003. PubMed ID: 16448696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
    Bernardo ME; Zaffaroni N; Novara F; Cometa AM; Avanzini MA; Moretta A; Montagna D; Maccario R; Villa R; Daidone MG; Zuffardi O; Locatelli F
    Cancer Res; 2007 Oct; 67(19):9142-9. PubMed ID: 17909019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources.
    Bernardo ME; Emons JA; Karperien M; Nauta AJ; Willemze R; Roelofs H; Romeo S; Marchini A; Rappold GA; Vukicevic S; Locatelli F; Fibbe WE
    Connect Tissue Res; 2007; 48(3):132-40. PubMed ID: 17522996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action.
    Astudillo P; Ríos S; Pastenes L; Pino AM; Rodríguez JP
    J Cell Biochem; 2008 Mar; 103(4):1054-65. PubMed ID: 17973271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients.
    Prata Kde L; Orellana MD; De Santis GC; Kashima S; Fontes AM; Carrara Rde C; Palma PV; Neder L; Covas DT
    Exp Hematol; 2010 Apr; 38(4):292-300.e4. PubMed ID: 20138957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology.
    Scharstuhl A; Schewe B; Benz K; Gaissmaier C; Bühring HJ; Stoop R
    Stem Cells; 2007 Dec; 25(12):3244-51. PubMed ID: 17872501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.
    Kern S; Eichler H; Stoeve J; Klüter H; Bieback K
    Stem Cells; 2006 May; 24(5):1294-301. PubMed ID: 16410387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray.
    Jeong JA; Hong SH; Gang EJ; Ahn C; Hwang SH; Yang IH; Han H; Kim H
    Stem Cells; 2005 Apr; 23(4):584-93. PubMed ID: 15790779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.